Neonatal Screening in Europe Revisited: An ISNS Perspective on the Current State and Developments Since 2010
Top Cited Papers
Open Access
- 5 March 2021
- journal article
- research article
- Published by MDPI AG in International Journal of Neonatal Screening
- Vol. 7 (1), 15
- https://doi.org/10.3390/ijns7010015
Abstract
Neonatal screening (NBS) was initiated in Europe during the 1960s with the screening for phenylketonuria. The panel of screened disorders (“conditions”) then gradually expanded, with a boost in the late 1990s with the introduction of tandem mass spectrometry (MS/MS), making it possible to screen for 40–50 conditions using a single blood spot. The most recent additions to screening programmes (screening for cystic fibrosis, severe combined immunodeficiency and spinal muscular atrophy) were assisted by or realised through the introduction of molecular technologies. For this survey, we collected data from 51 European countries. We report the developments between 2010 and 2020 and highlight the achievements reached with the progress made in this period. We also identify areas where further progress can be made, mainly by exchanging knowledge and learning from experiences in neighbouring countries. Between 2010 and 2020, most NBS programmes in geographical Europe matured considerably, both in terms of methodology (modernised) and with regard to the panel of conditions screened (expanded). These developments indicate that more collaboration in Europe through European organisations is gaining momentum. We can only accomplish the timely detection of newborn infants potentially suffering from one of the many rare diseases and take appropriate action by working together.Keywords
This publication has 34 references indexed in Scilit:
- Enhanced interpretation of newborn screening results without analyte cutoff valuesGenetics in Medicine, 2012
- Newborn screening programmes in Europe; arguments and efforts regarding harmonization. Part 1 – From blood spot to screening resultJournal of Inherited Metabolic Disease, 2012
- Newborn screening programmes in Europe; arguments and efforts regarding harmonization. Part 2 – From screening laboratory results to treatment, follow‐up and quality assuranceJournal of Inherited Metabolic Disease, 2012
- Neonatal screening in Europe; the situation in 2004Journal of Inherited Metabolic Disease, 2007
- Pitfalls of neonatal screening for very-long-chain acyl-CoA dehydrogenase deficiency using tandem mass spectrometryThe Journal of Pediatrics, 2006
- VLCAD deficiency: Pitfalls in newborn screening and confirmation of diagnosis by mutation analysisMolecular Genetics and Metabolism, 2006
- Clinical Effectiveness and Cost-Effectiveness of the Use of the Thyroxine/Thyroxine-Binding Globulin Ratio to Detect Congenital Hypothyroidism of Thyroidal and Central Origin in a Neonatal Screening ProgramPEDIATRICS, 2005
- Electrospray tandem mass spectrometry in the diagnosis of organic acidemiasRapid Communications in Mass Spectrometry, 1994
- Tandem mass spectrometry: A new method for acylcarnitine profiling with potential for neonatal screening for inborn errors of metabolismJournal of Inherited Metabolic Disease, 1990
- Über Ausscheidung von Phenylbrenztraubensäure in den Harn als Stoffwechselanomalie in Verbindung mit Imbezillität.Hoppe-Seyler´s Zeitschrift für physiologische Chemie, 1934